Gene: UHRF1
Official Full Name: ubiquitin like with PHD and ring finger domains 1provided by HGNC
Gene Summary: This gene encodes a member of a subfamily of RING-finger type E3 ubiquitin ligases. The protein binds to specific DNA sequences, and recruits a histone deacetylase to regulate gene expression. Its expression peaks at late G1 phase and continues during G2 and M phases of the cell cycle. It plays a major role in the G1/S transition by regulating topoisomerase IIalpha and retinoblastoma gene expression, and functions in the p53-dependent DNA damage checkpoint. It is regarded as a hub protein for the integration of epigenetic information. This gene is up-regulated in various cancers, and it is therefore considered to be a therapeutic target. Multiple transcript variants encoding different isoforms have been found for this gene. A related pseudogene exists on chromosome 12. [provided by RefSeq, Feb 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02462 | UHRF1 Knockout cell line (HeLa) | Human | UHRF1 | 1:3~1:6 | Negative | Online Inquiry |
KO02463 | UHRF1 Knockout cell line (HCT 116) | Human | UHRF1 | 1:2~1:4 | Negative | Online Inquiry |
KO02464 | UHRF1 Knockout cell line (HEK293) | Human | UHRF1 | 1:3~1:6 | Negative | Online Inquiry |
KO02465 | UHRF1 Knockout cell line (A549) | Human | UHRF1 | 1:3~1:4 | Negative | Online Inquiry |
UHRF1 Gene Knockout Cell Lines are genetically modified cell lines that have had the UHRF1 gene (Ubiquitin-like with PHD and RING Finger domains 1) inactivated using CRISPR-Cas9 technology. UHRF1 is crucial for maintaining DNA methylation and regulating histone modifications, making its study essential for understanding epigenetic mechanisms that influence gene expression, cell differentiation, and various diseases, including cancer. The knockout of this gene allows researchers to observe the downstream effects on cellular processes, providing insights into its role in epigenetic regulation.
These cell lines function by enabling scientists to conduct loss-of-function studies, thereby elucidating the biological pathways influenced by UHRF1. This investigation is crucial for examining how disruptions in epigenetic regulation can lead to pathophysiological conditions. In both research and clinical contexts, UHRF1 knockout cell lines contribute significantly to our understanding of cancer biology, stem cell differentiation, and the identification of potential therapeutic targets.
One of the standout advantages of UHRF1 Gene Knockout Cell Lines is their specificity and efficiency. Utilizing advanced CRISPR technology ensures high knockout rates with minimal off-target effects, which enhances the reliability of experimental results. Additionally, these cell lines provide a standardized model system that allows for reproducibility across different laboratories, a critical factor for scientific validation.
By choosing UHRF1 Gene Knockout Cell Lines, researchers and clinicians gain a powerful tool to dissect the complexities of epigenetic regulations in health and disease. This product not only advances fundamental biological research but also paves the way for novel therapeutic strategies. Our company, with its extensive expertise in genetic engineering and cell line development, prides itself on delivering high-quality biological products that facilitate groundbreaking research in molecular biology and related fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.